Your Messages Inbox
Your Article Summary
See Latest ArticlesERGONEX Pharma receives Frost & Sullivan's European Orphan Diseases Entrepreneurial Company Award 2009
b3c newswire, 10/20/09
ERGONEX Pharma received one of the prestigious ‘European Orphan Diseases Entrepreneurial Company Award’ on the occasion of Frost & Sullivan's '2009 Excellence in Healthcare Awards Banquet,' held in London on October 2009. The highly competitive award was presented to ERGONEX Pharma in recognition of the company's innovative therapeutic concept, its impressive display of technological know–how and targeted vision.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca and the Philadelphia Department of Public Health provide free medicines to Pennsylvanias uninsured
AstraZeneca, 11/24/09
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Amgen, 11/24/09
The Deal Names Abbott Top Dealmaker for Second Consecutive Year
Abbott, 11/23/09
Article Search
Sponsor